Erratum: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial (The Lancet (2010) 376(9753) (1647–1657) (S0140673610619241) (10.1016/S0140-6736(10)61924-1))
Arjen M. Dondorp, Caterina Fanello, Ilse C. E. Hendriksen, Ermelinda Gomes, Amir Seni, Kajal Chhaganlal, Kalifa Bojang, Rasaq Olaosebikan, NE Anunobi, Kathryn Maitland, Esther Kivaya, Tsiri Agbenyega, Samuel Blay Nguah, Jennifer Evans, Samwel Gesase, Catherine Kahabuka, George Mtove, Behzad Nadjm, Jacqueline Deen, Juliet Mwanga‐Amumpaire, M. Nansumba, C Karema, Noella Umulisa, Aline Uwimana, Olugbenga Ayodeji Mokuolu, O T Adedoyin, Wahab Babatunde Rotimi Johnson, Antoinette Tshefu, Marie Onyamboko, Tharisara Sakulthaew, Wirichada Pan‐ngum, K Silamut, Kasia Stepniewska, Charles J. Woodrow, Delia Bethell, Bridget Wills, Martina Oneko, Tünde Pető, Lorenz von Seidlein, Nick Day, Sir Nicholas White (2011). Erratum: Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial (The Lancet (2010) 376(9753) (1647–1657) (S0140673610619241) (10.1016/S0140-6736(10)61924-1)). , 377
